17 May 2023
19 May 2023
₹ 47.69 Cr
29 May 2023
₹1150 to ₹1229 per share
Remus Pharmaceuticals Limited is engaged in the marketing and distributing of finished formulations of pharmaceutical drugs. The portfolio consists of 429 products, as of January 31, 2023. They operate under different brand names across the globe. As on January 31, 2023, the company has 295 products registered in a total of 13 countries. As on January 31, 2023, a total of 134; products are under the process of registration in 16 countries.
The Remus Pharmaceuticals REIT IPO’s total issue size is ₹47.69 Crores
The company intends to utilize the net proceeds from the issue towards the funding of the following objects: 1. To Meet Working Capital Requirements 2. Funding investments for acquisitions and general corporate purposes 3. To meet Public Issue Expenses
Remus Pharmaceuticals REIT lot size is 100 shares.
The allotment date of Remus Pharmaceuticals IPO is set for 24th May, 2023
Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah, and Mrs. Anar Swapnil Shah are the Promoters of the company
Beeline Capital Advisors Pvt Ltd is the lead manager to the issue.